Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Palantir

Palantir Is Down, But Its FCF Could Make It Worth 21% More at $20 Per Share

Palantir Technologies stock is off its peak of $21.26 per share. But its powerful free cash flow could push PLTR stock up over 21% to that peak. One way investors can play this is to short OTM puts.

Barchart

Down 21%, Is Palantir Stock a Buy Right Now?

Palantir stock has pulled back sharply from its post-earnings peak - but the shares still trade at a premium, and Wall Street analysts think there may be more downside in store for this AI stock over the short term.

Barchart

PLTR vs. META: Which AI Growth Stock is Wall Street's Favorite for 2024?

While both Palantir and Meta Platforms are positioned for a stronger AI-fueled future in 2024, Wall Street is bullish on one stock's long-term prospects - and cautiously optimistic on the other.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Palantir (PLTR) and UiPath (PATH) - Buy, Hold, or Sell in 2024?

The software industry has been put under strain as a result of macroeconomic concerns. However, the future of the industry looks optimistic. Therefore, let us analyze whether software stocks Palantir Technologies (PLTR) and UiPath (PATH) are Buy, Hold, or Sell now.

StockNews.com

My plan to topple the Tory dark lords in 2024

We need a fellowship of socially conscious heroes to fight the Conservatives and NHS data-grabbing firms and save our democracy

The Guardian - UK

Good Law Project: US tech giant is offering to pay influencers to 'attack' us

THE Good Law Project has claimed a US tech giant has hired a PR firm to pay influencers to attack it on social media amid its investigation into an…

The National (Scotland)

Health workers blockade office of tech giant with NHS contract over ties to Israel

Demonstrators blockaded the central London office of US tech giant Palantir after it was awarded a contract worth hundreds of millions of pounds for…

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

Protesters blockade London office of tech giant with NHS contract over ties to Israel

Dozens of pro-Palestine demonstrators blocked the entrance to Palantir in central London

Evening Standard

Is Palantir Stock Really Headed to Just $5 Per Share?

Palantir stock has more than doubled in 2023, but lost 9% to start the week after a bearish analyst note. Are concerns about the AI software company's contract pipeline overdone, or is major downside ahead for the stock in 2024?

Barchart

Palantir Still Has Room to Rise, and Could Be Worth Up to 20% More

Palantir stock is still undervalued given its powerful free cash flow. With a 27% FCF margin and an FCF yield of 1.5% PLTR stock is worth 20% more. Shorting OTM puts is a good income play.

Barchart

You may balk at giving your health data to Palantir but it could save your life

The NHS’s deal with the US tech company raises privacy concerns but a unified database could be a medical gamechanger

The Guardian - UK

Palantir: privacy fears over handing NHS data to US defence provider show how lack of trust is holding back much-needed reform

Controversial US tech company Palantir has been awarded a £330 million contract to create a new system for sharing data – including patients’ medical details – within the NHS in England.

The Conversation

SNP MP grills Rishi Sunak over US tech firm's NHS contract

SNP MP Deidre Brock grilled Rishi Sunak at PMQs on Wednesday over NHS England’s awarding of an IT contract to US tech firm Palantir.

The National (Scotland)

The Guardian view on the NHS and Palantir: the case for this data deal looks weak

Editorial: Hiring a controversial US technology company to build an NHS data platform risks undermining public trust

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

13 inflation-proof stocks to buy for 2024

These companies are poised to ride the AI boom and protect investors from the impact of higher interest rates.

The Independent UK

Tech firm Palantir rejects concerns over role in NHS data platform plans

US tech giant Palantir has rejected concerns after the firm was awarded a contract worth hundreds of millions of pounds for a new NHS data platform.

Fortune

Peter Thiel-cofounded Palantir will overhaul the U.K.’s public health service in a deal worth up to $413m—and people are worried

Palantir previously worked with the NHS during COVID-19, helping with vaccine rollout for a grand sum of £1. But people remain skeptical about the deal.

The Independent UK

MPs to press new Health Secretary on NHS data platform plans

The health and social care committee said the Government has acknowledged it ‘needed to do better to communicate the benefits of digital healthcare’.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Palantir’s Peter Thiel: NHS is a natural target for outspoken tech billionaire

Silicon Valley outsider whose firm has won data contract has previously said health service should be ripped up to ‘start over’

The Guardian - UK

Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract

Awarding of contract to create new data platform prompts immediate concerns about security of medical records

The Guardian - UK

TechScape: Are social media giants silencing online content?

As violence on the ground continues, emotions on social media are higher than ever – with critics asking if platforms need more transparency around their algorithms

The National (Scotland)

NHS England gives contract to handle patient data to US spy tech firm

NHS England is set to hand over a key role in handling patient data to a US spy technology firm.

The Guardian - UK

NHS England gives key role in handling patient data to US spy tech firm Palantir

Exclusive: Company that works with intelligence services wins £480m contract in joint bid with Accenture

Barchart

Is It Too Late to Buy Palantir Stock?

Palantir stock has more than tripled in 2023, delivering outsized gains for shareholders. But it now trades at a premium valuation, and may pull back in the near term.

The Guardian - UK

Patients may shun new NHS data store over privacy fears, doctors warn

BMA raises concerns with minister about planned data platform, which could be run by US firm Palantir

1 … 51 52 53 54

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations